Podcasts about Obesity

Send a textDr. Gagandeep Singh joins Dr. Michael Koren to discuss his triangle approach, which combines the talents of a medical doctor, a nutritionist, and a trainer to tackle the medications, diets, and exercise changes needed to make a difference in metabolic diseases. Metabolic diseases include diabetes, hypertension, obesity, and polycystic ovary syndrome (PCOS). Dr. Singh, who practices in India, explains how this holistic approach has resulted in high success rates, with patients improving their lab numbers, losing weight, and reducing their medications as he "treats to success."Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a compelling array of advancements and strategic shifts that are shaping the healthcare landscape across the globe.In recent times, the pharmaceutical and biotech sectors have showcased remarkable resilience and innovation, driving forward with significant scientific breakthroughs and clinical trial results. A standout achievement comes from Novo Nordisk, whose recent Phase 2 trial results for its triple agonist targeting obesity reported a remarkable weight loss of up to 19.7% in patients over 24 weeks. This promising development positions Novo Nordisk as a formidable contender in the obesity treatment market, potentially affecting giants like Eli Lilly. With obesity being a significant global health challenge, these findings underscore the potential of multi-targeted approaches in managing this complex condition.Regulatory landscapes continue to evolve, with pivotal approvals marking milestones for therapies targeting rare diseases. Immedica Pharma's Loargys received FDA approval for treating hyperargininemia associated with arginase 1 deficiency, highlighting perseverance in overcoming regulatory hurdles after a prior rejection. Additionally, Sanofi and Regeneron's Dupixent achieved its ninth FDA approval, underscoring its versatile potential across multiple indications. These approvals not only reflect regulatory progress but also emphasize the critical role of persistence in drug development.Ethical considerations remain at the forefront of industry discussions, particularly highlighted by Novartis' settlement in a lawsuit concerning the use of Henrietta Lacks' cells without consent. This resolution underscores ongoing ethical challenges within biomedical research, emphasizing the need for ethical vigilance as companies increasingly rely on human-derived materials.Significant business trends are shaping strategic directions within the industry. Pfizer's acquisition of marketing rights for Sciwind's GLP-1 receptor agonist in China exemplifies a calculated move to dominate the obesity treatment market. This strategic acquisition allows Pfizer to leverage China's vast market potential for type 2 diabetes medications and positions it favorably for future weight loss treatments.On the manufacturing front, AbbVie has made substantial investments in U.S. infrastructure, committing $380 million to new North Chicago API plants as part of a decade-long strategy to inject $100 billion into U.S. operations. This initiative highlights a commitment to bolstering domestic production capabilities amidst global supply chain uncertainties.The complexities of drug development are further illustrated by Roche's decision to halt the development of Enspryng for Duchenne muscular dystrophy due to unsatisfactory progress. This shift in focus reflects the inherent challenges of drug repurposing and the necessity of robust clinical evidence to support new indications.Geopolitical factors also play a significant role in shaping industry dynamics, with recent U.S. Supreme Court decisions impacting international trade agreements. Such geopolitical influences can significantly affect pharmaceutical companies' operations and strategic planning.The collaboration between Astellas and Vir Biotechnology reflects another significant trend in strategic partnerships within the industry. Their $1.7 billion deal centered on a novel bispecific T-cell engager for prostate cancer underscores the growing importance of immuno-oncology and innovative approaches to targeting hard-to-treat cancers.The regulatory front continues to see transformative changes with the FDA unveiling draft guidance for a new approval pathway tailored for bespoke gene-editing therapies. This initiative could expedite personalized genetic treatments and transform patSupport the show

In this interview, Dr.SHIVA Ayyadurai, MIT PhD, Inventor of Email, Scientist, Engineer and Candidate for President, Talks about Black Pepper on Obesity: A Whole Systems Approach

In this episode we discuss: 
-The calories in calories out model of obesity  -What really causes fat storage  -Whether there are any concerns with consuming organ meats    
Free Energy Balance Food Guide: https://jayfeldmanwellness.com/guide 
The Nutrition Blueprint: https://mikefave.com/the-nutrition-blueprint/ 
Theresa's Instagram: https://www.instagram.com/livingrootswellness/   
Timestamps: 0:00 – intro  0:56 – Nick Norwitz's claim that calories don't cause obesity and whether we agree  6:25 – the value and limitations of calories   14:27 – the true cause of obesity  19:40 – “excess calorie intake causes weight gain” is unhelpful and irresponsible  23:28 – how and when measuring calorie intake can be valuable  27:24 – do calories matter?  32:28 – how “it's just calories” often places blame on the individual  34:26 – Nick Norwitz on when the calories-in-calories-out model “breaks”  37:28 – hypothyroidism and weight gain resolved using a bioenergetic approach  38:26 – thoughts on organ meats like liver, heart, kidney, stomach, and intestine  42:41 – freeze-dried or desiccated vs fresh organ meat  45:12 – Nutrition with Judy's claim that “liver is not a superfood”  47:11 – can you overdose micronutrients like vitamin A and copper from organ meats?  49:43 – strategies for including more organ meats in your diet

For a long time fat was seen simply as an inert yellow substance wrapping around our bodies, but now that's changing. Scientists are beginning to understand that our fat is actually intricate and dynamic, constantly in conversation with the rest of the body. It's now even considered by some to be an organ in its own right. To find out more about the complex role fat plays in our health, Ian Sample hears from co-host Madeleine Finlay and from Declan O'Regan, professor of cardiovascular AI at Imperial College London. Help support our independent journalism at theguardian.com/sciencepod

Dr. Christie Langenberg reviews the No. 5 article of 2024, titled “Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis,” which was originally published in The New England Journal of Medicine in October 2024. Dr. Jeremy Schroeder serves as the series host. Dr. Langenberg is a member of the Top Articles Subcommittee, and this episode is part of an ongoing mini journal club series highlighting each of the Top Articles in Sports Medicine from 2024, as selected for the 2025 AMSSM Annual Meeting. Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis: https://www.nejm.org/doi/full/10.1056/NEJMoa2403664

Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let's dive into the latest updates impacting clinicians and healthcare providers like you!Interested in a more traditional, text rundown? Check out the HCPFive!MAJESTY: Obinutuzumab Achieves 2 Year Complete Remission in Primary Membranous NephropathyObinutuzumab demonstrated superior complete remission rates at 2 years compared with tacrolimus in primary membranous nephropathy in the phase 3 MAJESTY trial, supporting a potential new B-cell–targeted standard of care.Ixekizumab, Tirzepatide Effective Together for Psoriasis and Obesity or OverweightIn adults with moderate-to-severe plaque psoriasis and obesity or overweight, combination therapy with ixekizumab and tirzepatide achieved superior skin clearance and weight reduction at 36 weeks compared with ixekizumab alone.AREXVY Vaccine Reduces Hospitalization, Major Adverse Cardiovascular Events in RSVReal-world data from over 2.5 million patients showed GSK's AREXVY vaccine was 75.6% effective against RSV-related hospitalization, with additional signals suggesting reduced in-hospital major adverse cardiovascular events in older adults.COMP360 Psilocybin Meets Primary Endpoint in Second Phase 3 Trial for TRDCOMP360 synthetic psilocybin met the primary endpoint in its second phase 3 trial in treatment-resistant depression, demonstrating significant symptom reduction at week 6 versus low-dose control and advancing toward potential regulatory submission.Thykamine Shows Disease-Modifying Potential in MASH Using Liver-on-a-Chip PlatformPreclinical data using a human liver-on-a-chip model suggest Thykamine may exert dose-dependent antifibrotic and anti-inflammatory effects in MASH, supporting further translational development.

On today's Good Day Health Show - ON DEMAND…Host Doug Stephan and Dr. Ken Kronhaus of Lake Cardiology (352-735-1400) cover a number of topics affecting our health. First up, Doug and Dr. Ken begin with a link between niacin and heart disease, supplements from real food vs synthetic supplements, and a publication of drinking sugary drinks and thinking working out will offset what you're putting in your body. Then, the conversation continues a focus on working out with a shift to benefits for mental health. Studies show dancing as a preferred form of working out can help combat depression. More good news about exercising show that those who regularly move for health are more likely to avoid getting extremely ill if they get COVID-19, possible even lowering their risk of getting the virus at all. Next up, evaluating 10 common illnesses and your risk factor with new genetic testing. These are nearly ready for use in doctors' offices to be used to evaluate genetic risk for A-fib, breast cancer, kidney disease, heart disease, high cholesterol, prostate cancer, asthma, types 1 and 2 Diabetes, and obesity. This will help in preventive medicine and help patients lower their risk of developing these diseases. The discussion shifts to listener questions, with one coming from Doug's son, who is dealing with Rheumatoid Arthritis (RA). As Dr. Ken explains, there is a breakthrough of a drug the will help to ease symptoms and prevents joint damage in RA patients. Another question discusses how cutting out meat can ease snoring and minimize a risk of sleep apnea. It's not just about shifting to a plant-based diet, but a healthy plant-based diet. Website: GoodDayHealthShow.com Social Media: @GoodDayNetworks

Welcome to Ozempic Weightloss Unlocked, where we dive into the latest on Ozempic from medical breakthroughs to real-life health impacts. Im here to unpack fresh news thats changing how we view this game-changer.A brand-new study from Rutgers University, published in the Journal of Medical Internet Research, reveals why so many stick with Ozempic despite side effects. Researchers analyzed sixty anonymous reviews on Drugs.com and found that sixty-two percent of users faced nausea, vomiting, or stomach issues, yet satisfaction soared when weight dropped. HealthDay News reports that sixty-seven percent experienced less appetite or fewer cravings for sugar and greasy foods, making the benefits outweigh the discomfort. Lead researcher Abanoub Armanious notes this cuts through social media hype to show everyday experiences: if youre losing weight, youre likely to keep going.Semaglutide, the key ingredient in Ozempic, mimics a hormone to control blood sugar, slow digestion, and curb hunger. Originally for type two diabetes, its now a weight loss powerhouse, with users seeing fifteen to twenty percent loss when paired with lifestyle tweaks, per UC Davis Health. But heres the catch: Physicians Committee research warns that stopping often leads to regaining two-thirds of the weight within a year, as the body rebounds with stronger cravings.Exciting advances are emerging. Georgia State Universitys Eric Krause found combining Ozempic-like drugs with anti-stress treatments boosts fat loss while sparing muscle and helps maintain results post-treatment. Plus, a daily oral semaglutide pill, approved this year, matches injections for thirteen to fifteen percent weight loss, according to Mount Sinai Health and the New England Journal of Medicine.Ozempic is transforming obesity care, but experts like those at UC Davis stress its best with diet, exercise, and doctor guidance to tackle root causes like stress or mental health hurdles. Note a recent retraction in the International Journal of Obesity on combo therapies, reminding us science evolves fast.Listeners, balance the wins with realities: results drive loyalty, but long-term success needs habits. Consult your doctor before starting.Thanks for tuning in, Ozempic Weightloss Unlocked listeners. Subscribe for more updates. This has been a quiet please production, for more check out quiet please dot ai. Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

Send a textHow the body's internal circadian clocks regulate metabolism, energy balance, and health.TOPICS DISCUSSED:Master circadian clock in the brain: Light detection via retina entrains the suprachiasmatic nucleus, which coordinates body-wide rhythms; intrinsic period slightly deviates from 24 hours, allowing seasonal flexibility.Peripheral clocks in organs: Nearly all cells have autonomous clocks; liver and fat clocks rapidly adjust to feeding time, while brain clock aligns more tightly to light.Clock mutations and metabolism: Disrupting core clock genes (e.g., CLOCK, BMAL1) causes obesity, liver fat accumulation, and impaired insulin secretion without hyperinsulinemia.Timing of food intake: Eating the same high-fat calories during rest phase causes more weight gain than during active phase due to differences in energy dissipation.Modern disruptions (jet lag, shift work, blue light): Create desynchrony between brain and peripheral clocks, contributing to metabolic issues; late-night eating impairs glucose handling.Critical illness & feeding: Tube feeding at night (opposite natural cycle) induces rapid insulin resistance, highlighting mismatch costs.Hormone rhythms: Testosterone, glucocorticoids, and others peak at specific times; misalignment affects stress, reproduction, and metabolism.Weight loss drugs & maintenance: GLP-1 drugs reduce intake effectively, but regain involves neuroendocrine adaptations tied to brain clock pathways.ABOUT THE GUEST: Joseph Bass, MD, PhD is Chief of Endocrinology, Metabolism and Molecular Medicine at Northwestern University Feinberg School of Medicine, Director of the Center for Diabetes and Metabolism, and a leading researcher who pioneered the link between circadian clock genes and metabolic disorders including obesity and diabetes.RELATED EPISODE:M&M 237 | Circadian Biology: Genetics, Behavior, Metabolism, Light, Oxygen & Melatonin | Joseph TakahashiSupport the showHealth Products by M&M Partners: SporesMD: Premium mushrooms products (gourmet mushrooms, nootropics, research). Use code 'nickjikomes' for 20% off. Lumen device: Optimize your metabolism for weight loss or athletic performance. MINDMATTER gets you 15% off. AquaTru: Water filtration devices that remove microplastics, metals, bacteria, and more from your drinking water. Through link, $100 off AquaTru Carafe, Classic & Under Sink Units; $300 off Freestanding models. Seed Oil Scout: Find restaurants with seed oil-free options, scan food products to see what they're hiding, with this easy-to-use mobile app. KetoCitra—Ketone body BHB + electrolytes formulated for kidney health. Use code MIND20 for 20% off any subscription (cancel anytime) For all the ways you can support my efforts

Discover how to lose weight without Ozempic using 5 evidence-backed strategies. This episode breaks down why insulin resistance is the real driver of weight gain and how cutting processed foods, eating only when hungry, fasting, weight resistance training, and detoxification can help you lose weight naturally and sustain it long-term — no prescription required. FEATURED PRODUCT The Good Poops Protocol is designed to support the exact systems discussed in this episode — liver detoxification, gut health, and blood sugar regulation. 

In this special edition on Obesity as a Chronic Disease our host, Dr. Neil Skolnik will discuss the root causes of obesity, the hormonal changes and metabolic adaptation that occurs when a person has obesity, and the implications of understanding obesity as a chronic disease for clinical practice. This special episode is supported by an independent educational grant from Lilly. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Donna Ryan, M.D, Professor Emeritus at the Pennington Biomedical Research Center in Baton Rouge, Louisiana. Past President of both the Obesity Society and the World Obesity Federation Susan Kuchera, M.D, Associate Clinical Professor of Family and Community Medicine in the Sidney Kimmel Medical College of Thomas Jefferson University, Program Director of the Jefferson Health Abington Family Medicine Residency Program. Selected references: Changes in Energy Expenditure Resulting from Altered Body Weight. N Engl J Med 1995;332:621-628 Long-Term Persistence of Hormonal Adaptations to Weight Loss. N Engl J Med 2011;365:1597-1604

Every single week in my clinic, I see smart, motivated people stuck in their weight loss journey not because they're doing something wrong, but because they believe something wrong. The myths surrounding weight loss are so deeply embedded in our culture that even some physicians still repeat them. And the cost? Shame, delayed treatment, and people giving up on themselves unnecessarily. I've spent over a decade watching these myths do real damage and I'm done staying quiet about it. In this episode, I'm breaking down the top 5 weight loss myths I wish my patients would stop believing and replacing them with what the science actually says. If you've ever said "I just need more willpower" this episode is for you. Listen now!   Episode Highlights: Why "calories in, calories out" is an oversimplification of a complex metabolic system How metabolic adaptation explains why what worked before stops working Why obesity is a chronic, relapsing disease  The truth about weight loss medications and why using them is NOT cheating Why the scale is just data, not a report card, and what metabolic progress really looks like Why stopping everything after weight loss leads to weight regain, and what to do instead   Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd   About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, "Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

Autism, Parenting, And The Art Of Ignoring Unsolicited Advice Julie Green had a very limited understanding of autism before her son was born. Navigating his diagnosis was difficult, especially when differing opinions were being thrown at them from all sides. Green reveals the realities of motherhood, autism, and self-discovery in her new book, Motherness. Guests: Julie M. Green, author, Motherness Host: Elizabeth Westfield Producer: Kristen Farrah     Kitchen Chemistry: The Cooking Oil That May Be Driving Obesity Though there are various cooking oils to choose from, soybean oil remains the most commercially popular choice in America. But is this cheap option making us obese? Our experts reveal how the high concentration of a particular fatty acid in this common oil may be influencing how our bodies store fat and contribute to rising health concerns. Guests:  Sonia P. Deol, assistant professional researcher in the department of microbiology and plant pathology, University of California, Riverside Frances M. Sladek, professor of cell biology & toxicologist, University of California, Riverside Host: Greg Johnson Producer:  Kristen Farrah   Medical Notes: How Energy Drinks May Worsen Your Cancer, A Non-Invasive Treatment For Seizures, And How To Fight Against Procrastination   Are energy drinks making you sick? A new treatment for seizures may soon be possible without the need for invasive brain surgery. Good news for sugar addicts! Scientists have created a healthier sweetener using tagatose. How to fight against procrastination. Host: Maayan Voss de Bettancourt Producer: Kristen Farrah Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Medsafe has quietly approved another weight loss drug, Mounjaro, which is now available by prescription in some New Zealand pharmacies. Obesity doctor, Dr Chaey Leem spoke to Ingrid Hipkiss.

This episode focuses on the challenges and strategies surrounding the cost and insurance coverage of anti-obesity medications. Guests share insights on navigating Medicare, Medicaid, and commercial insurance barriers, as well as tips for utilizing manufacturer programs, savings cards, and coding strategies to improve patient access. The discussion highlights the pharmacist's role in helping patients overcome financial obstacles and sustain access to effective obesity treatments. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Kitchen Chemistry: The Cooking Oil That May Be Driving ObesityThough there are various cooking oils to choose from, soybean oil remains the most commercially popular choice in America. But is this cheap option making us obese? Our experts reveal how the high concentration of a particular fatty acid in this common oil may be influencing how our bodies store fat and contribute to rising health concerns.Guests: Sonia P. Deol, assistant professional researcher in the department of microbiology and plant pathology, University of California, RiversideFrances M. Sladek, professor of cell biology & toxicologist, University of California, RiversideHost: Greg JohnsonProducers: Kristen Farrah Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Is fasting really the best way to lose fat — or is there a smarter, more strategic approach? In this masterclass episode, Vanessa introduces a powerful new concept: Protein Fasting — a structured approach using PSMF (Protein-Sparing Modified Fast) days to optimize fat loss, suppress appetite naturally, protect muscle, and potentially tap into fasting-like cellular signaling.

GLP-1s and bariatric surgery are powerful medical tools, and the real risk is starting them without understanding what long-term weight maintenance actually requires.This conversation pulls obesity treatment out of the culture wars and back into medicine. Dr. Betsy Dovec, one of the most experienced bariatric surgeons in the country,speaks plainly about what long-term care actually demands, whether someone chooses bariatric surgery, GLP-1 medications, or a combination of both. The question beneath it all is simple and uncomfortable: are you looking for a short-term result, or are you prepared for a long-term strategy?There is honesty here about weight regain, about the reality that stopping GLP-1 medications often leads to reversal, and about why a plan for maintenance matters more than the initial drop on the scale. The discussion touches on Microdosing GLP-1, the rise of GLP-1 oral medication, and how access and expectations shape outcomes. It also moves into GLP-1 for menopause and perimenopause, acknowledging how hormones change the metabolic equation for women and why GLP-1 inflammation benefits may explain why some feel better beyond weight loss alone.This episode challenges the shame narrative. Obesity is treated as a chronic metabolic condition influenced by biology, environment, and hormones. The deeper takeaway is not which tool to choose, but whether you are approaching your health with clarity about what sustainable care truly involves.Episode Breakdown:00:00 Bariatric Surgery Explained: What It Really Is09:11 Long-Term Weight Loss Success and Maintenance Strategies11:57 GLP-1 Medications, Ozempic, and Weight Regain Reality18:04 Hormones, Perimenopause, and GLP-1 for Women28:00 Visceral Fat, Fatty Liver, and Metabolic Risk37:01 Modern Bariatric Surgery and Recovery TimelineConnect with Dr. Betsy Dovec:Follow Dr. Dovec's InstagramVisit BodyByBariatrics WebsiteFollow BodyByBariatrics TikTok⁠⁠⁠⁠For More on this Episode: Read the full show notes ⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠

In this episode, you'll be listening to Jane Hughes, President of R&D and Co Founder of Verdiva Bio, and Jon Rees, CEO and cofounder of MitoRx Therapeutics. We'll discuss next-generation obesity solutions tackling GLP-1's muscle loss and adherence challenges, through innovative muscle preservation, oral administration and combination therapy.HostJennifer Smith-Parker, Director of Insights, BioSpaceGuestsJane Hughes, President of R&D and Co-founder, Verdiva BioJon Rees, CEO and Co-founder, MitoRx TherapeuticsDisclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

In this episode of The Jordan Syatt Podcast I speak with Jordan Lips (@jordanlipsfitness) and we discuss:- The top 3 glute exercises- The best sources of fiber- Surprisingly high quality protein sources- How heavy do you need to lift for strength and muscle?- Beginners guide to running- Oprah's "obesity gene"- The seed oil debate- The governments new nutrition guidelines- And more...I hope you enjoy this episode and, if you do, please leave a review on iTunes (huge thank you to everyone who has written one so far).Finally, if you've been thinking about joining The Inner Circle but haven't yet... we have hundreds of home and bodyweight workouts for you and you can get them all: https://www.sfinnercircle.com/

Discuss Pediatric Weight Gain Without Triggering ShameWhat would you say if a parent asked, “Can you tell my son he needs to lose weight?”That question sits at the center of one of the hardest conversations in pediatrics.In this episode, I'm joined by Dr. Amy Beck, clinical psychologist and expert in teen mental health and weight stigma, to unpack how we address pediatric obesity without causing unintended harm.Because this isn't just about weight. It's about protecting kids in a culture obsessed with body size, while still doing our job as clinicians.In this episode, we discuss:Common clinician missteps that unintentionally trigger shameWhy focusing on numbers (weight, BMI, carbs) can backfireHow to talk to a 5-year-old vs. a teenagerWhat to say when teens give one-word answersHow to navigate wo very different clinical scenarios:A teen in a larger body with normal labs but poor body imageRapid weight gain with elevated sugars, where intervention feels urgentWorking with teens is tough. Getting them to engage can feel even tougher.Dr. Beck shares practical language, strategies, and mindset shifts to help you intervene medically without triggering restriction, shutdown, or long-term harm.This episode is about striking the balance: preventing long-term medical complications while protecting a child's mental health in the process.Connect with Dr BeckHealth Psychology Partners Any Questions? Send Me a MessageSupport the showConnect with Colleen:InstagramLinkedInSign up for my FREE Newsletter - Nutrition hot-topics delivered to your inbox each week. Disclaimer: This podcast is a collection of ideas, strategies, and opinions of the author(s). Its goal is to provide useful information on each of the topics shared within. It is not intended to provide medical, health, or professional consultation or to diagnosis-specific weight or feeding challenges. The author(s) advises the reader to always consult with appropriate health, medical, and professional consultants for support for individual children and family situations. The author(s) do not take responsibility for the personal or other risks, loss, or liability incurred as a direct or indirect consequence of the application or use of information provided. All opinions stated in this podcast are my own and do not reflect the opinions of my employer.

With the launch of a new journal, the American Diabetes Association (ADA) is also launching a brand new podcast. The Points of CARE, the official podcast of Diabetes, Obesity, and Cardiometabolic CARE, will highlight key research findings, clinical implications, and emerging themes across diabetes, obesity, and cardiometabolic health through interviews with journal authors and subject-matter experts. In this special inaugural episode, host Richard Beaser, MD also discusses the ADA's Obesity Association and the "Standards of Care in Overweight and Obesity." 4:15 Beaser speaks with Alissa Segal, PharmD, RPh, CDCES, CDTC, FCCP. Dr. Segal is editor in chief of Diabetes, Obesity, and Cardiometabolic CARE and professor of pharmacy practice at the Massachusetts College of Pharmacy and Health Sciences. Her editorial, "Diabetes, Obesity, and Cardiometabolic CARE: Building New From a Strong Foundation," is available for free at doi.org/10.2337/doci25-0010. 13:00 Samar Hafida, MBCCh, joins the conversation. Dr. Hafida is a board-certified endocrinologist and weight management specialist at Boston Medical Center and assistant professor of medicine (Endocrinology, Diabetes, Nutrition & Weight Management) at the Boston University Chobanian & Avedisian School of Medicine. She is also vice president of the ADA's Obesity Association. Her editorial, "Introducing the Obesity Association and the Launch of Our Official Journal," is available for free at doi.org/10.2337/doci25-0012. 17:55 Dr. Hafida discusses "Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity." This article is available for free at doi.org/10.2337/doci25-0008. 20:05 Richard and Alissa highlight a few articles from the first issue of Diabetes, Obesity, and Cardiometabolic CARE. Simpkins et al. "Association of Type 2 Diabetes Subgroups With Incident Peripheral Neuropathy" doi.org/10.2337/doc25-0051 Livingston et al. "The Benefits and Costs of Treating Obesity Among Adults in the Medicaid Program" doi.org/10.2337/doci25-0005. Davidson et al. "Effectiveness of Using Patient-Defined Meal Sizes to Determine Bolus Doses of Insulin" doi.org/10.2337/doc25-0018 Ali et al. "Patterns of Prescription Discontinuation, Reinitiation, and Switching of Subcutaneous Semaglutide and Tirzepatide in Adults With Obesity" doi.org/10.2337/doc25-0026 Masiano et al. "Type 2 Diabetes Treatment and Experience With Hospitalization in Older Adults: A Convergent Mixed-Methods Study" doi.org/10.2337/doc25-0009 Young et al. "The Critical Role of Diabetology Pharmacists in Improving Cardiovascular-Kidney-Metabolic Care and Outcome" doi.org/10.2337/doc25-0049 To learn more about Diabetes, Obesity, and Cardiometabolic CARE please visit diabetesjournals.org/docm-care. Thank you for listening, and don't forget to subscribe.

Weight management expert Dr. Megha Poddar explains the science behind weight loss plateaus and why diets alone often fail in this podcast episode. She explains how the brain's reward system and our biology work to keep weight high, and highlights how obesity medications can play a role in long-term success...This episode is brought to you by ReliOn Community, an amazing program available exclusively for Walmart customers with a ReliOn Premier meter. Get free diabetes tips, recipes and support sent right to your phone - visit ReliOnBGM.com/community to learn more.For helpful resources, interviews with diabetes experts, and more, visit our website here: diabeteswhattoknow.com.All content of this channel is owned by What To Know, LLC. and is protected by worldwide copyright laws. You may download content only for your personal use (i.e., for non-commercial purposes) but no modification or further reproduction of the content is permitted. The content may otherwise not be copied or used in any way.The medical information in Diabetes - What To Know's content is provided as an information resource only. The content is not in any way intended to be nor should you rely on it as a substitute for professional medical evaluation, diagnosis, advice and treatment.Diabetes - What to Know ©️ 2026#diabetes #diabetesmanagement #t2d #t2diabetes #type2 #type2diabetes #healthy #diabetescare #weightmanagement

“For years, we told patients to ‘eat less, move more.' Now we know that's not the full story.” Obesity isn't a willpower problem—it's a complex medical condition tied to inflammation and heart risk.In this episode, Dr. Subodh Verma breaks down why belly fat matters most, how new GLP-1 therapies protect the heart itself, and why lifestyle & medication work together.This podcast was sponsored by Novo Nordisk Canada. It was created independently by My Weight - What to Know with no influence from Novo Nordisk.The medical information in My Weight - What to Know's content is provided as an information resource only. The content is not in any way intended to be nor should you rely on it as a substitute for professional medical evaluation, diagnosis, advice or treatment.All content of this channel is owned by What To Know, LLC. and is protected by worldwide copyright laws. You may download content only for your personal use (i.e., for non-commercial purposes) but no modification or further reproduction of the content is permitted. The content may otherwise not be copied or used in any way.My Weight - What to Know ©️ 2026

What will the obesity landscape look like in the next few years? Brooke Boyarski Pratt, founder and CEO of knownwell, shares her thoughts on the impact of GLP-1s on Breaking Health, hosted by Michelle Snyder. Boyarski Pratt also discusses the shifting mindset on treating obesity as a disease instead of just an issue of willpower, creating a space for obesity patients to feel comfortable seeking help, and the use of AI, as well as the impact of pivotal decisions toward company growth and lessons learned from expanding into new markets.  LINKS:    HealthEdge  McKesson Ventures knownwell, Inc.  

Living a Nutritious Life PodcastIn this episode of Nutritious Life Podcast, we are thrilled to welcome Natalie Jill, Licensed Master Sports Nutritionist, as her and Keri dive into the new dietary guidelines.About Our Guest:Natalie Jill is a Midlife Expert who helps women simplify complicated health topics and redefine healthy aging. With a top-rated podcast, “Midlife Conversations,” two best-selling Fat Loss Books that sold out in stores everywhere, and numerous TV appearances on shows like “The Doctors,” she built a high 7-figure Fat Loss business that transformed over 250,000 women's bodies and health. What You'll Learn in This - The history and evolution of the food pyramid and its impact on public health.- Why nutrition guidelines continue to change and how to interpret the latest science.- How to cut through nutrition noise, understand processed vs. whole foods, and make empowered choices.Episode Highlights- How marketing hijacked the food pyramid and spurred confusion for the public.- Why fruits and vegetables remain foundational, no matter how guidelines shift.- The drama and impact behind the new “flipped” food pyramid, and why simplicity matters.- Discussion about GLP-1 medications and their influence on the culture and food industry.About Living a Nutritious Life Podcast: Welcome to the Living a Nutritious Life podcast with Keri Glassman, MS, RDN, CDN, where we break down the latest nutrition science into smart, actionable tips to help you live your most nutritious life.On the Living a Nutritious Life podcast, Keri and her world-renowned guests cut through the noise, sharing unparalleled, forward-thinking tips, tricks, and the latest in health, wellness, and nutrition science.Why is nurturing your fascia just as important as what's being put on your plate? What foods in your pantry are silently disrupting your microbiome? How can hugging actually reduce inflammation in your body?Based on Keri's whole-person approach to healthy living, each impactful episode extends far beyond the simplistic “get more sleep” and “eat your greens” advice. She connects the dots like no one else – like how morning yoga can make it easier to choose a healthy lunch, leading to better sleep at night.Listen as Keri and her expert guests explore the physiological and behavioral connections that explain, for example, why the common wisdom around dieting and exercising alone doesn't work, so you can finally make the meaningful changes you've been looking for.Thank you for listening in to this episode of Living a Nutritious Life. We hope you enjoyed the conversation as much as we did! If you found value in this episode, please RATE, REVIEW and SHARE.Ready to Dive Deeper? Are you ready to dive into the world of nutrition and wellness even deeper and become a certified nutrition coach? Join our amazing global community of like-minded students and alumni. Get in on the action—enroll in our Become a Nutrition Coach program at nutritiouslife.com/bnc. Keri has a lot to teach, and we're here to help you get started on your journey!Connect with Natalie on social:Website: https://www.nataliejillfitness.com/Instagram: https://www.instagram.com/nataliejillfit/ TikTok: https://www.tiktok.com/@nataliejillfitFB: https://www.facebook.com/nataliejillfitYoutube: https://www.youtube.com/@nataliejillfitnessDownload your Flat Belly Guide - https://theflatbellyguide.comDownload your Age Optimizing Supplement Guide - https://ageoptimizer.com Links Mentioned in the Episode:Dietary Guidelines PDF: https://health.gov/dietaryguidelines/Connect with Keri on social: Instagram: https://www.instagram.com/nutritiouslifeofficial/ Instagram: https://www.instagram.com/keriglassman/ Facebook: https://www.facebook.com/KeriGlassmanNutritiousLife Pinterest: https://www.pinterest.com/nutritious_life/ Website: https://nutritiouslife.com/ Become a Nutrition Coach: https://nutritiouslife.com/bnc/Copyright © 2023-2025 Nutritious Life.#LivingaNutritiousLife #NutritiousLife Hosted on Acast. See acast.com/privacy for more information.

Summary In this episode of the Future of Dermatology podcast, Dr. Faranak Kamangar and Dr. Peter Lio discuss significant advancements in dermatology, including the recent approval of an ICD 10 code for topical steroid withdrawal, the exploration of botanicals in skin treatment, and the emerging understanding of the gut-skin connection. They also delve into the role of GLP medications in managing skin conditions and the exciting future developments in dermatology, particularly in the treatment of atopic dermatitis. Read the referenced documents at the following sites: - Ancient botanicals and the skin: Defining dermatologic ethnophytoconvergence as a translational framework for pharmacognosy: https://doi.org/10.1016/j.jdrv.2025.12.008 - The Gut-Skin Axis: Exploring the Role of SCFAs, Obesity, and GLP-1 Receptor Agonists in Atopic Dermatitis: https://jintegrativederm.org/article/view/109 - Topical Steroid Withdrawal is a Targetable Excess of Mitochondrial NAD+: https://www.medrxiv.org/content/10.1101/2024.04.17.24305846v1.full-text - Jennifer Fugo information: https://www.skinterrupt.com/book-a-session/ Takeaways - The CDC has approved an ICD 10 code for topical steroid withdrawal. - This approval allows for better study and understanding of TSW. - Diagnostic criteria for TSW are still being developed. - Topical steroid withdrawal may overlap with severe atopic dermatitis. - Non-steroidal treatments are becoming more prominent in dermatology. - Botanicals have been used across cultures for skin treatment. - The gut-skin connection is gaining attention in dermatology. - GLP medications may play a significant role in dermatological treatments. - The future of dermatology is promising with new treatments on the horizon. - A holistic approach to skin health is essential for effective treatment. Chapters 00:00 - Introduction to Dermatology Innovations 01:43 - Topical Steroid Withdrawal Breakthroughs 06:53 - Exploring Botanicals in Dermatology 09:15 - Gut-Skin Connection and Metabolic Health 13:42 - The Role of GLPs in Dermatology 19:42 - Future of Dermatology: Exciting Developments

Host Doug Stephan welcomes back Elizabeth Miller with Calotren. Unlike trendy quick fixes or stimulant-heavy diet pills, Calotren focuses on sustainable results by working with your body while you sleep. Taken at bedtime, it supports your natural overnight repair cycle to help improve sleep quality, reduce joint pain, support lean muscle retention, boost metabolism and daytime energy, and gently tone and tighten the skin. As we head into the season of sweets and comfort foods—Halloween candy, Thanksgiving feasts, and December's parade of cookies and pies—Calotren can help you stay on track, with users reporting fewer cravings, more energy, and steady inch and weight loss that lasts.Calotren naturally rebuilds lean muscle tissue, supports joint repair, and promotes better, more restorative sleep. With an 86% success rate in the first 90 days, most people notice improved sleep by the end of the first month, followed by consistent fat and inch loss in months two and three—without the rebound weight gain common with other methods. Doug and Elizabeth also explore the rising popularity of prescription weight-loss injections and explain why Calotren pairs safely with them, as maintaining lean muscle, stable energy, and healthy skin elasticity may make it an essential complement to those medications. To learn more, visit TopLoss.com and explore their interactive product page, or call 1-800-325-4366 with any questions. When you're ready to order, select “Shop Radio Sale” and use promo code DOUG at checkout for free shipping, and start your Calotren journey today.Website: GoodDayHealthShow.com Social Media: @GoodDayNetworks

Send a textDr. David G. Harper is a returning guest on our show! Be sure to check out his first appearance on episode 319 of Boundless Body Radio!Dr. David G. Harper is a health educator and cancer researcher, and has studied the impact of diet on human health for many years. The culmination of that extensive work is the BioDiet, a ketogenic food regimen that he created in 2012. The significant weight loss and health improvements he experienced led Dr. Harper to counsel thousands of people on the BioDiet, in clinical trials and on a personal basis, with consistent, impressive results.He is the author of the bestselling book BioDiet: The Scientifically Proven, Ketogenic Way to Lose Weight and Improve Health, which has become an international best-seller, reaching as high as #18 globally for books overall on Amazon.com. Dr. Harper is an Associate Professor of Kinesiology at the University of the Fraser Valley and a Visiting Scientist at the BC Cancer Research Center, Terry Fox Laboratory.He holds a Ph.D. from the University of British Columbia and completed a post-doctoral fellowship in comparative physiology at the University of Cambridge. He was on the Scientific Advisory Board of the Canadian Clinicians for Therapeutic Nutrition and a member of the Institute for Personalized Therapeutic Nutrition. He is a great friend and a great human being!Find Dr. Harper at-https://www.biodiet.org/LK- Dr. David G. HarperFB- @Dave HarperReciprocal Meat Conference June 21-24, 2026 in Amarillo, TX!How It's Made - Canola Oil! UNBELIVABLY DISGUSTING.Check out his amazing talk at Keto Salt Lake 2022!Find Boundless Body at-myboundlessbody.comFind Boundless Body at- myboundlessbody.com Book a session with us here!

 Claim your complimentary gift of my exclusive mini weight care guide today!Link: Weight Care Guide — Dr. Francavilla Show (thedrfrancavillashow.comHave you ever wondered which weight loss medication is actually right for you? With so many options out there—new GLP-1 medications like Wegovy and Zepbound, oral versions hitting the market, and older prescriptions—it can feel totally overwhelming.In this episode, we break it all down: how much weight you might realistically lose, how other health conditions factor in, cost considerations, who should avoid certain medications, and even how combination therapy can sometimes make sense.Over the years, I've covered these topics in different ways. One of my favorite episodes was with Dr. Angela Fitch, where we explored all the available medications at that time. Since then, new therapies like Zepbound and oral Wegovy have emerged, changing the landscape even more. This episode isn't meant to replace a one-on-one conversation with an obesity expert—that's still the gold standard—but it gives the information you need to start thinking about what might fit your goals, your body, and your lifestyle.By the end, you'll have a clearer picture of how these medications work, who they help most, and how to approach the decision thoughtfully and safely. Obesity is a medical condition, and like any condition, it deserves expert care—so let's dive into your options.Topics Covered:How Much Weight Can You Really Lose on GLP-1 Medications?The Other Medications That Still Play a Role in Weight LossWegovy vs. Zepbound: How Much Weight Loss Do You Actually Need?Why Weight Loss Is a Struggle—and How the Right Medication Makes the DifferenceResults Matter—But So Does the Price TagWho Should Avoid Certain Weight Loss MedicationsChoosing the Right Weight Loss Medication: Pills, Injections, and Personalized ApproachesDo You Really Need More Weight Loss?By the end of this episode, you'll have a clear understanding of the different weight loss medications, how they work, who they help most, and what to consider when choosing the right approach for your goals and health.For a deeper dive into each medication, real-world results, and expert insights on tailoring a plan that's safe, sustainable, and effective, the full episode is ready for you—it's packed with everything you need to make an informed decision about your weight loss journey.Referenced Episodes:Can a test tell me if Wegovy or Zepbound will work for me? With Dr.Andres Acosta of PhenomixMedications for Weight Loss with guest, Dr. Angela Fitch,Phentermine and Qsymia - What You Need to Know About These Weight LossOral Wegovy: All You Need to Know About This New Medication, with Joseph ZucchiConnect with me:Instagram: doctorfrancavillaFacebook: Help Your Patients Lose Weight with Dr. FrancavillaWebsite: Dr. Francavilla ShowYoutube: The Doctor Francavilla ShowGLP Strong: glpstrong.com

You're doing all the right things—showing up to the gym, getting your steps in, strength training—but that scale? Still not moving. Sound familiar? In this episode, I'm breaking down exactly how to eat to support your workouts without sabotaging your weight loss goals—and without overthinking it. No sports nutrition degree required, I promise. I've seen too many patients work incredibly hard in the gym only to undo their progress at the kitchen table. Exercise is powerful, but nutrition determines whether that exercise actually works for weight loss. And once you understand a few simple principles about pre- and post-workout nutrition, everything clicks into place. Learn why exercise alone doesn't guarantee weight loss, which common myths are holding you back, and how to fuel strategically for recovery and results.   Sign up for the Back on Track: Setting the Vision for your health Masterclass:  https://drshellymd.kit.com/ecc62a0638   Episode Highlights: Why exercise is powerful but nutrition determines whether it works for weight loss The truth about eating before and after workouts  Pre-workout fuel: when you need it, when you don't, and what actually works Post-workout recovery: protein targets, hydration basics, and avoiding the "reward" trap Special considerations for insulin resistance, PCOS, perimenopause, and GLP-1 users How to match your food to your workout type and intensity   Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd   About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, "Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

See omnystudio.com/listener for privacy information.

Extra body fat interferes with how vitamin D works after it enters your body, which explains why low levels often persist despite supplements or sun exposure Vitamin D can become trapped in fat tissue and fail to convert into its usable form, leaving blood tests low even when intake appears sufficient Deep belly fat and liver fat have the strongest impact on vitamin D availability, making waist size more important than body weight alone Taking higher doses of vitamin D doesn't always fix the problem if metabolic signals from excess fat remain unchanged Reducing visceral fat, restoring metabolic health, and supporting proper vitamin D activation help vitamin D function normally again

Everything You Need, One Place: https://swolenormous.com

Adipose tissue (body fat) isn't just “stored energy”—it's biologically active and can release inflammatory signals. For people living with inflammatory arthritis (like rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and lupus), that matters because it can influence pain, fatigue, disease activity, and sometimes even how well treatments work.In this video, Dr. Isabelle Amigues explains the intersection of overweight/obesity and inflammatory arthritis—without shame, and with a focus on what's actually helpful.We cover:Why fat tissue can contribute to inflammationHow weight can affect joints, symptoms, and functionWhat this can mean for arthritis outcomes and treatment responsePractical, compassionate next steps to support metabolic health and reduce inflammation#InflammatoryArthritis #RheumatoidArthritis #PsoriaticArthritis #AnkylosingSpondylitis #Lupus #AutoimmuneDisease #Rheumatology #Inflammation #AdiposeTissue #Obesity #MetabolicHealth #JointPain #ChronicIllness #HealthWithoutShame #HolisticHealth #TreatToTarget

In this special series on Oral GLP-1 Receptor Agonists, Dr. Neil Skolnik will discuss the first of the GLP-1 RAs to receive FDA approval, Semaglutide.  This special episode is sponsored with support from Novo Nordisk. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health W. Timothy Garvey, MD.,  Butterworth Professor and University Professor of Medicine in the Department of Nutrition Sciences at the University of Alabama at Birmingham. Selected references: Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial. Knop, Filip K et al. The Lancet, Volume 402, Issue 10403, 705 – 719 Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. Wharton Sean et al. N Engl J Med 2025;393:1077-1087 Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. Lincoff, A Michael, et al.  N Engl J Med 2023;389:2221-2232  

GLP-1 medications like Ozempic and Wegovy are everywhere—and so are the opinions. In this episode, Andrew breaks down what GLP-1 actually is (a natural gut hormone), how GLP-1 medications work, and why newer “dual agonist” options like Mounjaro/Zepbound tend to produce bigger weight-loss results. We also tackle the controversy: is obesity a disease, and are GLP-1s “taking the easy way out”?You'll hear a coach's perspective from years in the trenches—why weight loss is effortless for some people and brutally hard for others, what typical results look like, common side effects, why many people stop, and what usually happens when you discontinue the meds.Chapters00:00 — Why GLP-1s are “big” right now01:12 — How common is obesity and GLP-1 use?05:20 — Obesity as a disease09:10 — The blame game12:40 — Are GLP-1's the easy way out?23:16 — GLP 101: what it is and what it does31:30 — Results, side-effects, and plateausThe Co-Movement Gym Podcast is supported by Native Path Supplements and Lombardi Chiropractic.

Send a textDr. Erich Schramm and Dr. Michael Koren lead a presentation on diabetes and obesity in front of a live audience. The doctors talk about the role willpower plays, how ultra-processed foods hijack our brain, and what a healthy diet looks like. They also discuss the myriad signaling molecules in the body that tell us we're hungry or full and when to digest all that food. The doctors also touch on the growing line of medications that are being used to control diabetes and obesity, and how the two diseases play off of each other, which makes breaking the cycle difficult. The doctors close by talking about the surprising role a desert lizard plays in current weight-loss medications, and a sneak preview of other investigational medications on the horizon.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

"Iron Mike's" great comeback.     To advertise on our podcast, please reach out to sales@advertisecast.com or visit https://www.advertisecast.com/TheJeffWardShow

Luke Hanna holds a Master's degree in Obesity and Clinical Nutrition and a degree in Sport and Exercise Science. He has become one of my favourite authorities on evidence-based nutrition.Luke joins the podcast to break down the controversy surrounding the new American food pyramid - what it gets right, where it falls short, and why most people won't follow it regardless.THIS EPISODE COVERS:The attention and controversy surrounding the new American food pyramidWhat the updated pyramid gets wrongWhat it gets rightInconsistencies in the pyramid and media messagingWhether the new pyramid has been misrepresented compared to the old oneWhether people actually follow official governmental food guidesWhy Luke shifted his beliefs on saturated fat and LDL cholesterol — and what the evidence actually saysWhether strength training or cardio meaningfully increase appetite and lead to “eating back” burned caloriesCommon narratives around not needing fibreThe benefits of eating more fibreWhy restricting calories earlier in the day before a special occasion can sometimes backfireAnd much moreInstagram: @lukehannanutritionCHAPTERS00:38 Discussion on the New Food Pyramid03:03 Critique of the Guidelines04:49 Misrepresentation and Public Perception13:00 Alcohol Guidelines and Corporate Influence16:49 Practical Advice for Following Guidelines21:12 Policy Changes for Better Health23:32 Personal Reflections on Nutrition Beliefs27:50 Introduction to the Keto CTA Study28:40 Misrepresentation of Study Data29:16 The Importance of Context in Nutrition35:44 Exercise and Appetite: Myths and Facts41:53 Calorie Banking: Does It Work?45:56 The Benefits of Fibre50:04 Conclusion and Final ThoughtsSUPPORT THE SHOWIf this episode helped you think more clearly about nutrition guidelines and media messaging, you can support the show by:Subscribing and checking out more episodesSharing it on social media (tag me — I will respond)Sending it to someone confused about dietary guidelinesFOLLOW ANDREW COATESInstagram: @andrewcoatesfitnesshttps://www.andrewcoatesfitness.comPARTNERS AND RESOURCESRP Strength App (use code COATESRP)https://www.rpstrength.com/coatesJust Bite Me Meals (use code ANDREWCOATESFITNESS for 10 percent off)https://justbitememeals.com/MacrosFirst – FREE Premium TrialDownload MacrosFirstDuring setup, answer: How did you hear about us?Type: ANDREWKNKG Bags (15 percent off)https://www.knkg.com/Andrew59676Versa Gripps (discount link)https://www.versagripps.com/andrewcoatesTRAINHEROIC – FREE 90 Day Trial (2 steps)Go to: https://www.trainheroic.com/liftfreeReply to the email you receive (or email trials@trainheroic.com) and let them know Andrew sent you

Dr. Eryn and Coach Vinny sit down with Dr. Karl Nadolsky, a board-certified physician specializing in obesity and metabolic health, to explore why weight loss is far more complex than calories, willpower, or trends. The conversation covers scope of practice, responsible collaboration between physicians and coaches, and how obesity is often misunderstood by both the public and professionals. Dr. Nadolsky breaks down how GLP-1 medications are prescribed in real clinical settings, where compounded and off-label use creates risk, and what long-term outcomes actually look like when behavior change is missing. They also discuss ethical concerns, prevention, and the future of obesity treatment, along with Dr. Nadolsky's clinic model and why he moved away from insurance-driven care. This episode is a grounded, evidence-based discussion for anyone serious about metabolic health and sustainable fat loss. Coach VinnyEmail: vinny@balancedbodies.ioInstagram: vinnyrusso_balancedbodiesFacebook: Vinny Russo Dr. ErynEmail: dr.eryn@balancedbodies.ioInstagram: dr.eryn_balancedbodiesFacebook: Eryn Stansfield Dr. Karl NadolskyInstagram: drkarlnadolskyWebsite: endocrineclinicatthegym.comPodcast: DocsWhoLift Podcast LEGION 20% OFF CODEGo to https://legionathletics.com/ and use the code RUSSO for 20% off your order!

In this episode I sit down with my colleague to dive into how sports nutrition is growing in the tactical and high-performance field. He also shares practical tips to spot nutrition misinformation, gives his take on the new dietary guidelines, and more!Brandon Lee, DHSc, RD, CSSD, CCRP, FAND, is a human performance practitioner, researcher, and educator dedicated to advancing athlete health, readiness, and resilience. A Registered Dietitian and Board-Certified Specialist in Sports Dietetics, he serves as a Dietitian within the U.S. Army's Holistic Health and Fitness (H2F) system, providing performance nutrition support to more than 4,000 Soldiers in the 10th Mountain Division. His work integrates evidence-based practice, interdisciplinary collaboration, and applied research to optimize tactical performance and enhance Soldier lethality and recovery.Brandon's background spans clinical nutrition, long-term care, collegiate teaching, sports performance, and human nutrition research. He has contributed to high-performance environments, including Minor League Baseball and the Obesity and Metabolism Unit at UC Davis, where he coordinated research on dietary patterns and metabolic health.An active scholar and speaker, Brandon has published peer-reviewed and professional articles on low energy availability, overtraining, and tactical nutrition, and he presents regularly at national and state conferences. He also serves on advisory boards and has held multiple leadership and service roles within professional organizations.Brandon earned his Doctor of Health Science from PennWest University and is recognized as a Fellow of the Academy of Nutrition and Dietetics.In this episode Stevie chats with Brandon about:What is encompassed in the growing field of tactical nutritionCollaboration being key to be a better practitioner and to better support the individual athleteThe three pillars of evidence-based practiceHot takeaways from the new dietary guidelinesAnd so much more!Stay connected:Check out Brandon's professional profile hereFollow along with Brandon's work on LinkedInFollow Stevie on Instagram: @stevielynlynJoin Stevie's newsletter: Stevie Lyn Nutrition newsletter

In this episode, Dr. Greg Jones sits down with Dr. Sharon Hausman-Cohen, Chief Medical Officer of IntelliXX DNA, to explore how medical genomics is transforming the way we understand heart disease, brain health, inflammation, and metabolism. Most people think genetics stops at traits like eye color or ancestry. Genomics goes much deeper—analyzing how thousands of genes interact to influence cardiovascular risk, cognitive function, clotting tendencies, nutrient metabolism, and chronic inflammation.Dr. Hausman-Cohen explains why many direct-to-consumer DNA tests fall short, how incomplete interpretation can mislead patients, and why clinician-guided genomic analysis allows for truly personalized care. The conversation also dives into inflammation, methylation, homocysteine, cholesterol myths, caffeine metabolism, mitochondrial health, and women's unique clotting risks.Whether you're trying to reduce your risk of heart disease, improve mental clarity, or understand how your biology responds to diet, supplements, and medications—this episode offers a science-based roadmap for precision health.

How did weight-loss drugs move from medical niche to global phenomenon Aimee Donnellan, Reuters columnist and author of Off the Scales: The Inside Story of Ozempic and the Race to Cure Obesity, joins Karl Henry on this week's episode of The Real Health podcast. This episode of The Indo Daily is brought to you by our sister podcast, Real Health with Karl Henry See omnystudio.com/listener for privacy information.

What happens when the world of GLP-1s collides with the operating room? Today, we're diving into the new era of obesity care. Hosts·       Matthew Martin, trauma and bariatric surgeon at the University of Southern California/Los Angeles General Medical Center (Los Angeles, California) @docmartin2·       Adrian Dan, bariatric and MIS surgeon, program director for the advanced MIS bariatric and foregut fellowship at Summa Health System (Akron, Ohio) @DrAdrianDan·       Crystal Johnson Mann, bariatric and foregut surgeon at the University of Florida (Gainesville, Florida) @crys_noelle_·       Katherine Cironi, general surgery resident at the University of Southern California/Los Angeles General Medical Center (Los Angeles, California) @cironimacaroniLearning objectives1.          Understand the evolving role of OMMs in bariatric surgical practice·       Recognize how widespread GLP-1 and dual-incretin therapies have reshaped patient presentations, expectations, and referral patterns.·       Appreciate current evidence comparing surgery to GLP-1 therapy, including the JAMA Surgery study out of Allegheny Health (2025), noting:o   Superior weight loss with bariatric surgery (~28% TBWL vs ~10% with GLP-1s)o   Higher health-care utilization and cost in GLP-1–treated patients.·       Frame OMMs not as alternatives but as complementary tools within a chronic disease model when treating obesity.2.           Review pharmacologic classes and their expected efficacy·       Surgeons should be able to articulate the mechanisms, efficacy, and limitations of:o   GLP-1 receptor agonists – incretin-based satiety; 5–12% TBWL.o   Dual GIP/GLP-1 agonists – most potent agents; 15–22% TBWL.o   Sympathomimetics – norepinephrine-driven appetite suppression; 3–7% TBWL.o   Combination agents (bupropion-naltrexone, phentermine-topiramate) – 5–12% TBWL depending on regimen.o   Emerging therapies – retatrutide, maritide, oral GLP-1s, with promising TBWL in phase 2 trials3.          Apply OMMs strategically in the preoperative phase·       Integrate OMMs without compromising surgical eligibility—OMM-related weight loss does not negate the indication for surgery.·       Counsel patients that medication response does not equal disease resolution; surgery remains the most durable intervention.·       Manage delayed gastric emptying and aspiration risk:o   Pause weekly GLP-1 or dual agonists for ≥1 week pre-op (longer if symptomatic).o   Collaborate closely with the anesthesia/OR teams·       Screen for nutritional depletion before surgery, especially protein deficits exacerbated by appetite suppression.·       Navigate insurance barriers that may paradoxically approve surgery but deny medication continuation.4.          Implement postoperative OMMs safely and effectively·       Establish criteria for OMM introduction:o   Typical initiation at 6–12 months, once the diet stabilizes and the physiologic curve flattens.o   Earlier initiation (4–6 weeks) may be appropriate in pediatric or select high-risk populations.·       Recognize altered pharmacokinetics after sleeve and bypass:o   Injectables may be preferred due to altered absorption of oral agents.·       Prevent postoperative nutritional compromise:o   Monitor protein intake, hydration, and micronutrient status (including iron, B12, and fat-soluble vitamins).o   Titrate doses slowly to minimize nausea/vomiting that can precipitate malnutrition.·       Frame OMM use as a tool for disease persistence (plateau/regain), not as a marker of failure.5.          Identify systems-level barriers and the implementation of coordinated care·       Understand insurance inconsistencies—coverage for surgery is often not paired with coverage for long-term medical therapy.·       Clearly document disease persistence and medical necessity when appealing denials.·       Avoid fragmented care: establish shared-care pathways between bariatric surgery, obesity medicine, and primary care.·       Use patient-centered language emphasizing complementary therapy, not hierarchy or competition between surgery and medications.6.          Counsel patients ethically and accurately within a chronic disease model·       Set expectations: sustained success requires surgery + medication + behavioral change.·       Educate patients that postoperative OMM use does not imply surgical failure.·       Normalize long-term multimodal management of obesity, analogous to diabetes or hypertension models.*Sponsor Disclaimer: Visit goremedical.com/btkpod to learn more about GORE® SYNECOR Biomaterial, including supporting references and disclaimers for the presented content.  Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

View This Week's Show NotesStart Your 7-Day Trial to Mobility CoachJoin Our Free Weekly Newsletter: The AmbushIn this episode of The Ready State Podcast, we're joined by Dr. Kevin Hall—one of the world's leading metabolism researchers and a longtime NIH scientist—for a wide-ranging conversation on what the research actually says about weight loss, energy balance, and the modern food environment.Dr. Hall explains what we've learned from real-world and tightly controlled studies, including his work following The Biggest Loser contestants, and why exercise doesn't fully prevent the metabolic adaptations that can accompany major weight loss. We also unpack why “calories in, calories out” is both true in principle and often misunderstood in practice, how ultra-processed foods can drive overeating, and what GLP-1 medications may be changing in appetite biology.The episode also touches on Dr. Hall's departure from a 21-year career at the NIH, following the censorship of his team's findings on ultra-processed foods when they didn't align with preferred narratives—an experience he describes as chilling for scientific communication.Finally, we explore the practical challenges of doing high-quality nutrition research, why confident opinions can outpace the data, and what it will take to better understand—and ultimately prevent—diet-related chronic disease.What You'll Learn in This EpisodeWhy metabolism isn't “broken” — and why larger bodies burn more calories at restWhat the Biggest Loser study actually revealed about weight loss and regainWhy exercise doesn't “save” your metabolism during extreme dietingHow ultraprocessed foods change how much people eat — without acting like addictive drugsWhy calories in vs. calories is often misunderstood in practiceHow genetics and environment interact to shape body weightWhat GLP-1 drugs are really doing — and what they don't fixWhy nutrition science is underfunded, politicized, and desperately neededChapters(00:00) - Kevin Hall, PhD, Metabolism Researcher(01:01) - Dr. Hall on the Ready State Podcast(04:10) - Misconceptions About Metabolism(04:54) - The Biggest Loser Study & Metabolism Influence(13:09) - Challenges in Nutrition Research(19:10) - Metabolism's Role in Weight Loss(22:13) - Vitality Blueprint: Importance of Blood Work(25:45) - Calories In, Calories Out: Simplistic View?(30:45) - Understanding GLP-1 Agonists(32:20) - The Food Environment's Impact(36:05) - Ultra-Processed Foods and Caloric Intake(38:02) - The Complexity of Obesity(41:40) - Solutions for Our Food System(48:23) - Causes of Brain Fog(49:34) - Element: Nutritional Insights(51:39) - RFK Jr. Discussion(01:01:40) - Politics' Influence on Science(01:04:35) - Leaders in Nutrition Science(01:06:48) - Can Weight Loss Be Achieved?(01:08:10) - Universal Diets: Myth or Reality?(01:12:35) - Why Doritos Lead to Overeating(01:13:21) - Understanding Visceral Fat(01:14:04) - Momentous: Nutritional Products(01:20:25) - Book/TV Show/Music Recommendations(01:21:11) - Connecting with Dr. Hall(01:21:52) - OutroConnect with KevinWebsite | Bluesky | X | LinkedInBook: Food Intelligence: The Science of How Food Both Nourishes and Harms UsCheck out The Biggest Loser Study2019 Study: Ultra-Processed Diets Cause Excess Calorie Intake and Weight GainHuge thanks to our sponsors, Vitality, Momentous, and LMNT.

In this episode, I sit down with one of my former mentors and professors, Dr. Alan Penzias, Medical Director at Boston IVF and Associate Professor at Harvard Medical School, to discuss his recent editorial in the Annals of Internal Medicine titled "The Weighty Issue of Obesity and Reproductive Success."  Read the full show notes on Dr. Aimee's website.  We dive deep into how age and weight factor into the fertility equation and why these conversations are so critical for anyone trying to conceive. Dr. Penzias shares his decades of experience helping patients navigate the complex intersection of body mass index, maternal age, and reproductive success, offering practical guidance on when to seek treatment and how to optimize your health before trying to get pregnant. In this episode, we cover: How age remains the strongest predictor of fertility success and why both partners should consider timing The U-shaped curve of BMI and fertility: why both low and high body mass index can impact conception Practical strategies for doctors for discussing weight and fertility with patients in a shame-free, empowering way When to prioritize immediate fertility treatment versus taking time for weight optimization based on age The role of GLP-1 medications (like Tirzepatide) in fertility treatment and safe protocols for use Why unexplained infertility may have hidden explanations related to weight and metabolic health The "do the as if" philosophy: building sustainable health habits one step at a time Resources: Dr. Alan Penzias and Boston IVF: BostonIVF.com Dr. Penzias's editorial: "The Weighty Issue of Obesity and Reproductive Success" - Annals of Internal Medicine https://www.acpjournals.org/doi/10.7326/ANNALS-25-02742  Dr. Penzias's YouTube video: "Evidence-Based Approach to Unexplained Infertility" https://youtu.be/9j4lNvmaXts?si=zmMFZFOno0sWnhcn  American Society for Reproductive Medicine (ASRM) Practice Committee resources on overweight and fertility https://www.asrm.org/ Dr. Stephanie Fein  - Fertility Weight Loss Specialist: https://www.stephaniefeinmd.com/  Hillary Wright, Nutritionist at Boston IVF: https://www.bostonivf.com/physicians/hillary-wright Do you have questions about IVF?Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, February 9, 2026 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom.   Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org. Other ways to connect with Dr. Aimee and The Egg Whisperer Show: Subscribe to my YouTube channel for more fertility tips!Subscribe to the newsletter to get updates  

Adolescent obesity is rapidly turning into a worldwide health emergency. The World Health Organization (WHO) reports that over 160 million children and teenagers ages 5 to 19 are now overweight or obese A new study from the University of Gothenburg collected data from nearly one million Swedish men and found that obese teenagers are more likely to experience severe infections later in life Obesity is a chronic medical condition characterized by excess body fat that impairs health and leads to symptoms such as fatigue, shortness of breath, joint pain, and metabolic issues that tend to worsen over time Body mass index (BMI) has traditionally been the standard for assessing weight and health, but it has come under scrutiny because it frequently misclassifies risk You can tackle obesity at its root by eliminating metabolic health hazards like seed oils and ultraprocessed foods and instead, choosing healthy carbs and walking more

About this episode: Following decades of surging adult obesity rates, numbers have leveled out since 2022. But with GLP-1s dominating culture, nutrition guidelines shifting, and funding for chronic diseases vanishing, the state of obesity is set to undergo even more change. In this episode: J. Nadine Gracia returns to Public Health On Call to talk about the latest State of Obesity report from Trust for America's Health. Guests: Dr. J. Nadine Gracia, MSCE, is the president and CEO of the Trust for America's Health, a nonprofit, nonpartisan public health policy, research, and advocacy organization that promotes optimal health for every person and community. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs. Show links and related content: State of Obesity Report 2025 : Better Policies for a Healthier America—Trust for America's Health RealFood.gov—U.S. Department of Health and Human Services Dismantling CDC's chronic disease center 'looks pretty devastating' to public health experts—STAT Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.